Brief: Nautilus Biotechnology Q1 EPS USD -0.15
30/04/2024 13:00
Apr 30 (Reuters) - Nautilus Biotechnology Q1 operating expenses USD 21.607 million. * Q1 net income USD -18.73 million
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11